10x Genomics Inc
TXGNASDAQStock · Data from SEC EDGAR 13F · Held by 11 of 87 tracked investors
10x Genomics Inc at a glance
An overview of the financial statements, in plain language. Switch to the advanced view for charts.
- Valuation8
- Growth48
- Profitability5
- Quality54
- Debt100
- Stability36
- ✓It has more cash than debt.
- !The company is loss-making: net profit is negative.
- !The stock is expensive: you pay 1,017.6 USD for 1 USD of annual earnings.
The score describes the quality and the past of the company based on its statements (the FinBoss model, indicative). A high score is not a buy signal and a low one is not a sell signal. Data source: Yahoo Finance, prices and statements in USD.
Is the stock expensive?
ExpensiveThe company has no earnings, so the P/E cannot be calculated.
- P/E
- –
- P/S
- 16.5×
- EV/EBITDA
- -235.2×
Is the company growing?
Growing slowlyRevenue over 3 years grew 7.6% a year. Last year -12.7%.
Does it make money?
Loss-makingChart TXG
Insider purchases
last 90 days, SEC Form 4Which investors hold this stock
11CW Cathie Wood ARK Investment Management | 2.49% |
SD Stanley Druckenmiller Duquesne Family Office | 0.3% |
HM Harvard Management Company Harvard Management Company | 0.15% |
SC Steven Cohen Point72 Asset Management | 0.08% |
JS Jim Simons Renaissance Technologies | 0.04% |
CA Cliff Asness AQR Capital Management | 0.03% |
JG Joel Greenblatt Gotham Asset Management | 0.01% |
KG Ken Griffin Citadel Advisors | 0.01% |
RD Ray Dalio Bridgewater Associates | 0% |
Ns Norský státní fond Norges Bank | 0% |
Šn Švýcarská národní banka Swiss National Bank | 0% |
Frequently asked questions
How much is 10x Genomics Inc (TXG) stock?
10x Genomics Inc shares trade at $78.02, +6.94% over the last trading day. The price is delayed.
What is the market cap of 10x Genomics Inc?
The market cap of 10x Genomics Inc is about $10.2B.
Which big investors hold 10x Genomics Inc?
According to the latest 13F filings, 11 of 87 tracked investors hold 10x Genomics Inc, for example Cathie Wood, Stanley Druckenmiller, Harvard Management Company.
When will 10x Genomics Inc report its next results?
The next earnings report of 10x Genomics Inc is expected on 5 Nov 2026.
Source: SEC EDGAR 13F-HR (quarterly filings). The data is indicative and is not investment advice.